Research Programs

Potential break-throughs in the making

Vodobatinib (SCC-138)

c-Abl inhibitor for treating neurodegenerative disorders

Vodobatinib (SCO-088)

BCR ABL1 inhibitor for treating Chronic Myeloid Leukemia


Anti-MUC-1 ADC for treatment of solid tumours

Vibozilimod (SCD-044)

S1PR1 agonist for treating auto-immune disorders


Topical drug for treatment of Alopecia Areata

Copyright @ 2024. All Rights Reserved.
Follow Us :